We recommend
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study
Veloxis Pharmaceuticals
One-Year Results of Phase 3, Double-Blind, Randomized Trial in De Novo Kidney Transplant Patients
Veloxis Pharmaceuticals
Two-Year Results of Phase 3, Double-Blind, Randomized Trial in De Novo Kidney Transplant Patients
Veloxis Pharmaceuticals
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate Release Tacrolimus versus Extended Release Tacrolimus in African American Kidney Transplant Recipients
Veloxis Pharmaceuticals
Review One-Year Results of Phase 3, Double-Blind, Randomized Trial in De Novo Kidney Transplant Patients
Veloxis Pharmaceuticals
A Steady-State, Head-to-Head, Pharmacokinetic Comparison: An Open-Label, Randomized, Crossover Study
Veloxis Pharmaceuticals